Global Cord Blood Corporation (CORBF) Research

Global Cord Blood Corporation, headquartered in Central, Hong Kong, primarily offers umbilical cord blood preservation and related support services within the People's Republic of China. The company's operations include the comprehensive testing, processing, and long-term storage of cord blood samples for its individual clients. Additionally, it undertakes the examination, preparation, and storage of donated cord blood units, facilitating their use for matching purposes. As of March 31, 2022, the corporation oversaw the management of three distinct cord blood banks, located in Beijing municipality, Guangdong province, and Zhejiang province. The entity previously operated as China Cord Blood Corporation, adopting its current name in March 2018, and functions as a subsidiary of Blue Ocean Structure Investment Company Ltd.

Market snapshot

Symbol
CORBF
Price
$0.95
Day change
0.00%
Market cap
$861.9M
P/E ratio
1.56x
52-week range
0.2-1.75
Sector
Healthcare
Industry
Medical - Diagnostics & Research

Peer companies

  • Bioqual, Inc. (BIOQ)
  • The Cannabist Company Holdings Inc. (CBSTF)
  • Cordlife Group Limited (CLIFF)
  • Drug Free Solution, Inc. (DSOL)
  • iAnthus Capital Holdings, Inc. (ITHUF)
  • Medical Developments International Limited (MDDVF)
  • Novacyt S.A. (NVYTF)
  • Vivos Inc. (RDGL)

Open Global Cord Blood Corporation (CORBF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.